Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?
Authors
Keywords
Prostaglandin E2, Overactive bladder, Biomarker, Botulinum toxin type-A
Journal
BMC Urology
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-11-05
DOI
10.1186/1471-2490-14-85
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarkers in overactive bladder
- (2013) Alka A. Bhide et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
- New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
- (2013) Karl-Erik Andersson Therapeutics and Clinical Risk Management
- Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB)
- (2012) Amar Mohee et al. BJU INTERNATIONAL
- Botulinum Toxin A Versus Placebo for Refractory Detrusor Overactivity in Women: A Randomised Blinded Placebo-Controlled Trial of 240 Women (the RELAX Study)
- (2012) Douglas G. Tincello et al. EUROPEAN UROLOGY
- Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics
- (2012) Kang Jun Cho et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
- OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
- (2012) Victor W. Nitti et al. JOURNAL OF UROLOGY
- Effect of Bothersome Overactive Bladder Symptoms on Health-related Quality of Life, Anxiety, Depression, and Treatment Seeking in the United States: Results From EpiLUTS
- (2012) Ian Milsom et al. UROLOGY
- Overactive bladder symptoms have a variety of causes
- (2012) M. J. Dickson et al. BMJ-British Medical Journal
- Novel biomarkers for overactive bladder
- (2011) Rufus Cartwright et al. Nature Reviews Urology
- Wertigkeit des „nerve growth factor“ beim Syndrom der überaktiven Blase
- (2011) S. Knippschild et al. UROLOGE
- Wirkung von Botulinumtoxin A in der ein- und mehrmaligen Behandlung der überaktiven Blase
- (2010) C. Frohme et al. UROLOGE
- Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity
- (2009) Hsin-Tzu Liu et al. BJU INTERNATIONAL
- Long-lasting breaches in the bladder epithelium lead to storage dysfunction with increase in bladder PGE2 levels in the rat
- (2008) Rikiya Shioyama et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study
- (2008) Karin S. Coyne et al. BJU INTERNATIONAL
- Persistence of antimuscarinic drug use
- (2008) Søren Brostrøm et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search